Anti-tumor effects of crocetin and related molecular targets

Journal of Cellular Physiology

Volumn 233, Issue 3, 2018, Pages 2170-2182

  Moradzadeh, Maliheh ^a   Sadeghnia, Hamid Reza ^a   Tabarraei, Alijan ^b   Sahebkar, Amirhossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cancer; crocetin; Crocus sativus; saffron

Indexed keywords

CROCETIN; ANTINEOPLASTIC AGENT; CAROTENOID; NUCLEIC ACID SYNTHESIS INHIBITOR;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; COLORECTAL CANCER; CROCUS SATIVUS; DRUG STABILITY; ESOPHAGUS CANCER; GENOTOXICITY; HUMAN; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MOLECULARLY TARGETED THERAPY; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SKIN CANCER; STOMACH CANCER; UTERINE CERVIX CANCER; APOPTOSIS; CHEMISTRY; CHEMOPROPHYLAXIS; CROCUS; DRUG EFFECTS; NEOPLASM; PROCEDURES; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAROTENOIDS; CELL LINE, TUMOR; CHEMOPREVENTION; CROCUS; HUMANS; NEOPLASMS; NUCLEIC ACID SYNTHESIS INHIBITORS;

EID: 85035040109     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25953     Document Type: Review

References (97)

1. Abdullaev, F., Riveron-Negrete, L., Caballero-Ortega, H., Hernández, J. M., Perez-Lopez, I., Pereda-Miranda, R., & Espinosa-Aguirre, J. (2003). Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicology in Vitro, 17(5), 731–736.
2. Abdullaev, F. I. (1994). Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicology Letters, 70(2), 243–251.
3. Abdullaev, F. I. (2002). Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Experimental Biology and Medicine, 227(1), 20–25.
4. Amin, A., Hamza, A. A., Bajbouj, K., Ashraf, S. S., & Daoud, S. (2011). Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology, 54(3), 857–867.
5. Asai, A., Nakano, T., Takahashi, M., & Nagao, A. (2005). Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. Journal of Agricultural and Food Chemistry, 53(18), 7302–7306.
6. Ashrafi, M., Bathaie, S., Taghikhani, M., & Moosavi-Movahedi, A. (2005). The effect of carotenoids obtained from saffron on histone H1 structure and H1-DNA interaction. International Journal of Biological Macromolecules, 36(4), 246–252.
7. Bajbouj, K., Schulze-Luehrmann, J., Diermeier, S., Amin, A., & Schneider-Stock, R. (2012). The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines. BMC Complementary and Alternative Medicine, 12(1), 69.
8. Bathaie, S. Z., Bolhasani, A., Hoshyar, R., Ranjbar, B., Sabouni, F., & Moosavi-Movahedi, A.-A. (2007). Interaction of saffron carotenoids as anticancer compounds with ctDNA, Oligo (dG. dC) 15, and Oligo (dA. dT) 15. DNA and Cell Biology, 26(8), 533–540.
9. Bathaie, S. Z., Hoshyar, R., Miri, H., & Sadeghizadeh, M. (2013). Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer. Biochemistry and Cell Biology, 91(6), 397–403.
10. Bathaie, S. Z., Miri, H., Mohagheghi, M.-A., Mokhtari-Dizaji, M., Shahbazfar, A.-A., & Hasanzadeh, H. (2013). Saffron aqueous extract inhibits the chemically-induced gastric cancer progression in the wistar albino rat. Iranian Journal of Basic Medical Sciences, 16(1), 26–38.
11. Bhattacharjee, B., Vijayasarathy, S., Karunakar, P., & Chatterjee, J. (2012). Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. Asian Pacific Journal of Cancer Prevention, 13(11), 5605–5611.
12. Caballero-Ortega, H., Pereda-Miranda, R., & Abdullaev, F. I. (2007). HPLC quantification of major active components from 11 different saffron (Crocus sativus L.) sources. Food Chemistry, 100(3), 1126–1131.
13. Carmona, M., Zalacain, A., Sánchez, A. M., Novella, J. L., & Alonso, G. L. (2006). Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruits. Tentative identification of seven new compounds by LC-ESI-MS. Journal of Agricultural and Food Chemistry, 54(3), 973–979.
14. Chahine, N., Hanna, J., Makhlouf, H., Duca, L., Martiny, L., & Chahine, R. (2013). Protective effect of saffron extract against doxorubicin cardiotoxicity in isolated rabbit heart. Pharmaceutical Biology, 51(12), 1564–1571.
15. Chen, B., Hou, Z.-H., Dong, Z., & Li, C.-D. (2015). Crocetin downregulates the proinflammatory cytokines in methylcholanthrene-induced rodent tumor model and inhibits COX-2 expression in cervical cancer cells. BioMed Research International, Article ID 829513.
16. Chryssanthi, D. G., Dedes, P. G., Karamanos, N. K., Cordopatis, P., & Lamari, F. N. (2011). Crocetin inhibits invasiveness of MDA-MB-231 Breast cancer cells via downregulation of matrix metalloproteinases. Planta Medica, 77(02), 146–151.
17. Chryssanthi, D. G., Lamari, F. N., Iatrou, G., Pylara, A., Karamanos, N. K., & Cordopatis, P. (2007). Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Research, 27(1A), 357–362.
18. Corti, P., Mazzei, E., Ferri, S., Franchi, G., & Dreassi, E. (1996). High performance thin layer chromatographic quantitative analysis of picrocrocin and crocetin, active principles of saffron (Crocus sativusL.-Iridaceae): a new method. Phytochemical Analysis, 7(4), 201–203.
19. D'Alessandro, A. M., Mancini, A., Lizzi, A. R., De Simone, A., Marroccella, C. E., Gravina, G. L., … Festuccia, C. (2013). Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer. Nutrition and Cancer, 65(6), 930–942.
20. Das, I., Das, S., & Saha, T. (2010). Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological study. Acta Histochemica, 112(4), 317–327.
21. Dhar, A., Mehta, S., Dhar, G., Dhar, K., Banerjee, S., Van Veldhuizen, P., … Banerjee, S. K. (2009). Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Molecular Cancer Therapeutics, 8(2), 315–323.
22. Dropcho, E. J. (2011). The neurologic side effects of chemotherapeutic agents. CONTINUUM: Lifelong Learning in Neurology, 17(1 Neurologic Complications of Systemic Disease), 95–112.
23. Dufresne, C., Cormier, F., & Dorion, S. (1997). In vitro formation of crocetin glucosyl esters by Crocus sativus callus extract. Planta Medica, 63(02), 150–153.
24. Feizzadeh, B., Tavakkol Afshari, J., Rakhshandeh, H., Rahimi, A., Brook, A., & Doosti, H. (2008). Cytotoxic effect of saffron stigma aqueous extract on human transitional cell carcinoma and mouse fibroblast. Urology Journal, 5(3), 161–167.
25. Festuccia, C., Mancini, A., Gravina, G. L., Scarsella, L., Llorens, S., Alonso, G. L., … Lenzi, A. (2014). Antitumor effects of saffron-derived carotenoids in prostate cancer cell models. BioMed Research International, Article ID 135048.
26. Gainer, J., Wallis, D., & Jones, J. (1976). The effect of crocetin on skin papillomas and Rous sarcoma. Oncology, 33(5–6), 222–224.
27. GHAFFARII, M. (2005). Separation and purification of some components of iranian saffron. Asian Journal of Chemistry, 17(2), 725–729.
28. Giaccio, M. (2004). Crocetin from saffron: An active component of an ancient spice. Critical Reviews in Food Science and Nutrition, 44(3), 155–172.
29. Hadjzadeh, M., Tavakol Afshari, J., Ghorbani, A., & Shakeri, M. (2006). The effects of aqueous extract of garlic (Allium sativum L.) on laryngeal cancer cells (Hep-2) and L929 cells in vitro. Journal of Medicinal Plants, 2(18), 41–48.
30. Hafezi Ghahestani, Z., Alebooye Langroodi, F., Mokhtarzadeh, A., Ramezani, M., & Hashemi, M. (2016). Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin. Artificial Cells, Nanomedicine, and Biotechnology [E-pub ahead of print]. https://doi.org/10.1080/21691401.2016.1198359
31. He, K., Si, P., Wang, H., Tahir, U., Chen, K., Xiao, J., … Xiang, G. (2014). Crocetin induces apoptosis of BGC-823 human gastric cancer cells. Molecular Medicine Reports, 9(2), 521–526.
32. He, M.-L., Cheng, X.-W., Chen, J.-K., & Zhou, T.-S. (2006). Simultaneous determination of five major biologically active ingredients in different parts of Gardenia jasminoides fruits by HPLC with diode-array detection. Chromatographia, 64(11-12), 713–717.
33. Hosseini, A., Mousavi, S. H., Ghanbari, A., Shandiz, F. H., Raziee, H. R., Rad, M. P., & Mousavi, S. H. (2015). Effect of saffron on liver metastases in patients suffering from cancers with liver metastases: A randomized, double blind, placebo-controlled clinical trial. Avicenna Journal of Phytomedicine, 5(5), 434.
34. Hosseinzadeh, H., Abootorabi, A., & Sadeghnia, H. R. (2008). Protective effect of crocus sativus stigma extract and crocin (trans-crocin 4) on Methyl Methanesulfonate-induced DNA damage in mice organs. DNA and Cell Biology, 27(12), 657–664.
35. Hosseinzadeh, H., & Nassiri-Asl, M. (2013). Avicenna's (Ibn Sina) the Canon of Medicine and saffron (Crocus sativus): a review. Phytotherapy Research: PTR, 27(4), 475–483.
36. Jagadeeswaran, R., Thirunavukkarasu, C., Gunasekaran, P., Ramamurty, N., & Sakthisekaran, D. (2000). In vitro studies on the selective cytotoxic effect of crocetin and quercetin. Fitoterapia, 71(4), 395–399.
37. Javadi, B., Sahebkar, A., & Emami, S. A. (2013). A survey on saffron in major islamic traditional medicine books. Iranian Journal of Basic Medical Sciences, 16(1), 1–11.
38. Kanakis, C. D., Tarantilis, P. A., Tajmir-Riahi, H.-A., & Polissiou, M. G. (2007a). Interaction of tRNA with safranal, crocetin, and dimethylcrocetin. Journal of Biomolecular Structure and Dynamics, 24(6), 537–545.
39. Kanakis, C. D., Tarantilis, P. A., Tajmir-Riahi, H. A., & Polissiou, M. G. (2007b). Crocetin, dimethylcrocetin, and safranal bind human serum albumin: Stability and antioxidative properties. Journal of Agricultural and Food Chemistry, 55(3), 970–977.
40. Kim, S. H., Lee, J. M., Kim, S. C., Park, C. B., & Lee, P. C. (2014). Proposed cytotoxic mechanisms of the saffron carotenoids crocin and crocetin on cancer cell lines. Biochemistry and Cell Biology, 92(2), 105–111.
41. Konoshima, T., Takasaki, M., Tokuda, H., Morimoto, S., Tanaka, H., Kawata, E., … Molnar, J. (1998). Crocin and crocetin derivatives inhibit skin tumour promotion in mice. Phytotherapy Research, 12(6), 400–404.
42. Koul, A., & Abraham, S. K. (2017). Intake of saffron reduces gamma-radiation-induced genotoxicity and oxidative stress in mice. Toxicology Mechanisms and Methods [E-pub ahead of print]. https://doi.org/10.1080/15376516.2017.1307476
43. Langroodi, F., Hafezi Ghahestani, Z., Alibolandi, M., Ebrahimian, M., & Hashemi, M. (2016). Evaluation of the effect of crocetin on antitumor activity of doxorubicin encapsulated in PLGA nanoparticles. Nanomedicine Journal, 3(1), 23–34.
44. Lautenschläger, M., Lechtenberg, M., Sendker, J., & Hensel, A. (2014). Effective isolation protocol for secondary metabolites from Saffron: Semi-preparative scale preparation of crocin-1 and trans-crocetin. Fitoterapia, 92, 290–295.
45. Li, N., Lin, G., Kwan, Y.-W., & Min, Z.-D. (1999). Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography. Journal of Chromatography A, 849(2), 349–355.
46. Li, S., Jiang, S., Jiang, W., Zhou, Y., Shen, X. Y., Luo, T., … Wang, H. Q. (2015). Anticancer effects of crocetin in human esophageal squamous cell carcinoma KYSE-150 cells. Oncology Letters, 9(3), 1254–1260.
47. Liu, T., & Qian, Z. (2002). [Pharmacokinetics of crocetin in rats]. Yao Xue Xue Bao=Acta Pharmaceutica Sinica, 37(5), 367–369.
48. Lopresti, A. L., & Drummond, P. D. (2014). Saffron (Crocus sativus) for depression: A systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology, 29(6), 517–527.
49. Lozano, P., Castellar, M., Simancas, M., & Iborra, J. (1999). A quantitative high-performance liquid chromatographic method to analyse commercial saffron (Crocus sativus L.) products. Journal of Chromatography A, 830(2), 477–483.
50. Lucas, C. D., Hallagan, J. B., & Taylor, S. L. (2001). The role of natural color additives in food allergy. Advances in Food and Nutrition Research, 43, 195–216.
51. Magesh, V., DurgaBhavani, K., Senthilnathan, P., Rajendran, P., & Sakthisekaran, D. (2009). In vivo protective effect of crocetin on benzo (a) pyrene-induced lung cancer in Swiss albino mice. Phytotherapy Research, 23(4), 533–539.
52. Magesh, V., Singh, J. P. V., Selvendiran, K., Ekambaram, G., & Sakthisekaran, D. (2006). Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Molecular and Cellular Biochemistry, 287(1-2), 127–135.
53. Martin, G., Goh, E., & Neff, A. (2002). Evaluation of the developmental toxicity of crocetin on Xenopus. Food and Chemical Toxicology, 40(7), 959–964.
54. Mathews-Roth, M. (1982). Effect of crocetin on experimental skin tumors in hairless mice. Oncology, 39(6), 362–364.
55. Miller, T. L., Willett, S. L., Moss, M. E., Miller, J., & Belinka, B. A. (1982). Binding of crocetin to plasma albumin. Journal of Pharmaceutical Sciences, 71(2), 173–177.
56. Modaghegh, M.-H., Shahabian, M., Esmaeili, H.-A., Rajbai, O., & Hosseinzadeh, H. (2008). Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine, 15(12), 1032–1037.
57. Monsuez, J.-J., Charniot, J.-C., Vignat, N., & Artigou, J.-Y. (2010). Cardiac side-effects of cancer chemotherapy. International Journal of Cardiology, 144(1), 3–15.
58. Mousavi, S. H., Tavakkol-Afshari, J., Brook, A., & Jafari-Anarkooli, I. (2009). Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food and Chemical Toxicology, 47(8), 1909–1913.
59. Nair, S., Panikkar, K., & Parthod, R. (1993). Protective effects of crocetin on the bladder toxicity induced by cyclophosphamide. Cancer Biotherapy & Radiopharmaceuticals, 8(4), 339–343.
60. Nair, S., Pannikar, B., & Panikkar, K. (1991). Antitumour activity of saffron (Crocus sativus). Cancer Letters, 57(2), 109–114.
61. Nair, S., Varghese, C. D., Paniker, K., Kurumboor, S., & Parathod, R. (1994). Effects of saffron on Vitamin A levels and its Antitumour activity on the growth of solid tumours in mice. International Journal of Pharmacognosy, 32(2), 105–114.
62. Nussbaumer, S., Bonnabry, P., Veuthey, J.-L., & Fleury-Souverain, S. (2011). Analysis of anticancer drugs: A review. Talanta, 85(5), 2265–2289.
63. Ozaki, A., Kitano, M., Furusawa, N., Yamaguchi, H., Kuroda, K., & Endo, G. (2002). Genotoxicity of gardenia yellow and its components. Food and Chemical Toxicology, 40(11), 1603–1610.
64. Parizadeh, M. R., Ghafoori Gharib, F., Abbaspour, A. R., Tavakol Afshar, J., & Ghayour-Mobarhan, M. (2011). Effects of aqueous saffron extract on nitric oxide production by two human carcinoma cell lines: Hepatocellular carcinoma (HepG2) and laryngeal carcinoma (Hep2). Avicenna Journal of Phytomedicine, 1(1), 43–50.
65. Pfander, H., & Rychener, M. (1982). Separation of crocetin glycosyl esters by high-performance liquid chromatography. Journal of Chromatography A, 234(2), 443–447.
66. Premkumar, K., Abraham, S. K., Santhiya, S., Gopinath, P., & Ramesh, A. (2001). Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug and Chemical Toxicology, 24(4), 421–428.
67. Premkumar, K., Abraham, S. K., Santhiya, S., & Ramesh, A. (2003). Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice. Phytotherapy Research, 17(6), 614–617.
68. Premkumar, K., Thirunavukkarasu, C., Abraham, S., Santhiya, S., & Ramesh, A. (2006). Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice. Human & Experimental Toxicology, 25(2), 79–84.
69. Rangarajan, P., Subramaniam, D., Paul, S., Kwatra, D., Palaniyandi, K., Islam, S., … Putty, S. (2015). Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Oncotarget, 6(29), 27661.
70. Rouhi Boroujeni, H., & Kiani, S. (2015). Therapeutic effects of Crocus sativus: An overview of systematic reviews. Advanced Herbal Medicine, 1(3), 48–55.
71. Sadeghnia, H. R., Ghorbani Hesari, T., Mortazavian, S. M., Mousavi, S. H., Tayarani-Najaran, Z., & Ghorbani, A. (2014). Viola tricolor induces apoptosis in cancer cells and exhibits antiangiogenic activity on chicken chorioallantoic membrane. BioMed Research International, Article ID 625792.
72. Saklani, A., & Kutty, S. K. (2008). Plant-derived compounds in clinical trials. Drug Discovery Today, 13(3), 161–171.
73. Salomi, M. J., Nair, S. C., & Panikkar, K. R. (1991). Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutrition and Cancer, 16(1), 67–72.
74. Samarghandian, S., Afshari, J. T., & Davoodi, S. (2011). Suppression of pulmonary tumor promotion and induction of apoptosis by Crocus sativus L. extraction. Applied Biochemistry and Biotechnology, 164(2), 238–247.
75. Samarghandian, S., Borji, A., Farahmand, S. K., Afshari, R., & Davoodi, S. (2013). Crocus sativus L. (saffron) stigma aqueous extract induces apoptosis in alveolar human lung cancer cells through caspase-dependent pathways activation. BioMed Research International, 2013, 417928.
76. Samarghandian, S., Boskabady, M. H., & Davoodi, S. (2010). Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line. Pharmacognosy Magazine, 6(24), 309.
77. Sano, K., & Himeno, H. (1987). In vitro proliferation of saffron (Crocus sativus L.) stigma. Plant Cell. Tissue and Organ Culture, 11(3), 159–166.
78. Schmidt, M., Betti, G., & Hensel, A. (2007). Saffron in phytotherapy: Pharmacology and clinical uses. WMW Wiener Medizinische Wochenschrift, 157(13), 315–319.
79. Shu, L., Cheung, K.-L., Khor, T. O., Chen, C., & Kong, A.-N. (2010). Phytochemicals: Cancer chemoprevention and suppression of tumor onset and metastasis. Cancer and Metastasis Reviews, 29(3), 483–502.
80. Siddikuzzaman, Guruvayoorappan, C., & Berlin Grace, V. (2011). All trans retinoic acid and cancer. Immunopharmacology and Immunotoxicology, 33(2), 241–249.
81. Steele, V. E., Kelloff, G. J., Wilkinson, B. P., & Arnold, J. T. (1990). Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Research, 50(7), 2068–2074.
82. Sujata, V., Ravishankar, G., & Venkataraman, L. (1992). Methods for the analysis of the saffron metabolites crocin, crocetins, picrocrocin and safranal for the determination of the quality of the spice using thin-layer chromatography, high-performance liquid chromatography and gas chromatography. Journal of Chromatography A, 624(1-2), 497–502.
83. Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., … Dang, Y. (2011). Anti-cancer natural products isolated from chinese medicinal herbs. Chinese Medicine, 6(1), 27.
84. Tarantilis, P., Morjani, H., Polissiou, M., & Manfait, M. (1993). Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Research 14(5A), 1913–1918.
85. Tavakkol-Afshari, J., Brook, A., & Mousavi, S. H. (2008). Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food and Chemical Toxicology, 46(11), 3443–3447.
86. Tseng, T.-H., Chu, C.-Y., Huang, J.-M., Shiow, S.-J., & Wang, C.-J. (1995). Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Letters, 97(1), 61–67.
87. Tsimidou, M., & Tsatsaroni, E. (1993). Stability of saffron pigments in aqueous extracts. Journal of Food Science, 58(5), 1073–1075.
88. Umigai, N., Murakami, K., Ulit, M., Antonio, L., Shirotori, M., Morikawa, H., & Nakano, T. (2011). The pharmacokinetic profile of crocetin in healthy adult human volunteers after a single oral administration. Phytomedicine, 18(7), 575–578.
89. Wang, C.-J., Hsu, J.-D., & Lin, J.-K. (1991). Suppression of aflatoxin B1-induced hepatotoxic lesions by crocetin (a natural carotenoid). Carcinogenesis, 12(10), 1807–1810.
90. Wang, C.-J., Lee, M.-J., Chang, M.-C., & Lin, J.-K. (1995). Inhibition of tumor promotion in benzo [a] pyrene-initiated CD-1 mouse skin by crocetin. Carcinogenesis, 16(2), 187–191.
91. Wang, C.-J., Shiah, H.-S., & Lin, J.-K. (1991). Modulatory effect of crocetin on aflatoxin B 1 cytotoxicity and DNA adduct formation in C3H10T12 fibroblast cell. Cancer Letters, 56(1), 1–10.
92. Wang, C.-J., Shiow, S.-J., & Lin, J.-K. (1991). Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Carcinogenesis, 12(3), 459–462.
93. Wang, C. J., Cheng, T. C., Liu, J. Y., Chou, F. P., Kuo, M. L., & Lin, J. K. (1996). Inhibition of protein kinase C and proto-oncogene expression by crocetin in NIH/3T3 cells. Molecular Carcinogenesis, 17(4), 235–240.
94. Zalacain, A., Ordoudi, S., Blazquez, I., Díaz-Plaza, E. M., Carmona, M., Tsimidou, M., & Alonso, G. (2005). Screening method for the detection of artificial colours in saffron using derivative UV-Vis spectrometry after precipitation of crocetin. Food Additives and Contaminants, 22(7), 607–615.
95. Zhang, M., Hu, P., Liang, Q., Yang, H., Liu, Q., Wang, Y., & Luo, G. (2007). Direct process integration of extraction and expanded bed adsorption in the recovery of crocetin derivatives from Fructus gardenia. Journal of Chromatography B, 858(1), 220–226.
96. Zhong, Y.-, Shi, F., Zheng, X.-, Wang, Q., Yang, L., Sun, H., … Qin, Y. (2011). Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and-independent mechanisms. Acta Pharmacologica Sinica, 32(12), 1529–1536.
97. Zougagh, M., Simonet, B., Rios, A., & Valcarcel, M. (2005). Use of non-aqueous capillary electrophoresis for the quality control of commercial saffron samples. Journal of Chromatography A, 1085(2), 293–298.